Prevalence of Respiratory Complications in Chronic Kidney Disease Patients: A Cross-sectional Study

Abstract Background: Respiratory complications are increasingly recognized as significant comorbidities in chronic kidney disease (CKD) patients, yet their prevalence and clinical characteristics remain inadequately documented in the Indian population. Objectives: This study aimed to determine the prevalence, types, and severity of respiratory complications in CKD patients across different disease stages and to identify the association between kidney function decline and pulmonary dysfunction. Methods: A cross-sectional observational study involving 150 CKD patients (stages 1–5) from Kidney Care Centre, Tirunelveli was conducted. Respiratory assessment included modified Medical Research Council (mMRC) dyspnea scale, spirometry, 6-minute walk test (6MWT), peripheral oxygen saturation (SpO₂), chest imaging, and modified Borg exertion scale. Multivariate analysis examined associations between CKD stage and respiratory complications. Results: Pulmonary edema was the most prevalent respiratory complication (24.84%), followed by pneumonia (18.2%), pleural effusion (16.5%), tuberculosis (12.3%), and obstructive sleep apnea (10.1%). Mean FEV₁ % predicted significantly declined from Stage 1 (95%) to Stage 5 (42%, p<0.001). Mean 6MWT distance decreased progressively (Stage 1: 487m vs Stage 5: 268m, p<0.001). Dyspnea severity correlated significantly with advancing CKD stage (r=0.78, p<0.001). SpO₂ below 92% was observed in 31.3% of Stage 4–5 patients. Multivariate analysis identified CKD stage (OR=2.41, 95% CI: 1.89–3.07), dialysis status (OR=1.87, 95% CI: 1.23–2.84), and anemia (OR=1.56, 95% CI: 1.02 2.38) as independent predictors of respiratory complications. Conclusion: Respiratory complications are highly prevalent in CKD patients with significant functional impairment and disease progression across kidney stages. Early respiratory assessment and integrated management strategies are essential for comprehensive CKD care and improved patient outcomes.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-14
DOI
https://doi.org/10.5281/zenodo.18809633
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Respiratory Complications in Chronic Kidney Disease Patients: A Cross-sectional Study

P. Muthukrishnan, M. Nisarudeen, S. Bavani
Zenodo (CERN European Organization for Nuclear Research)
Dialysis and Renal Disease Management
article

Prevalence of Respiratory Complications in Chronic Kidney Disease Patients: A Cross-sectional Study

P. Muthukrishnan, M. Nisarudeen, S. Bavani
article en

Abstract

Abstract Background: Respiratory complications are increasingly recognized as significant comorbidities in chronic kidney disease (CKD) patients, yet their prevalence and clinical characteristics remain inadequately documented in the Indian population. Objectives: This study aimed to determine the prevalence, types, and severity of respiratory complications in CKD patients across different disease stages and to identify the association between kidney function decline and pulmonary dysfunction. Methods: A cross-sectional observational study involving 150 CKD patients (stages 1–5) from Kidney Care Centre, Tirunelveli was conducted. Respiratory assessment included modified Medical Research Council (mMRC) dyspnea scale, spirometry, 6-minute walk test (6MWT), peripheral oxygen saturation (SpO₂), chest imaging, and modified Borg exertion scale. Multivariate analysis examined associations between CKD stage and respiratory complications. Results: Pulmonary edema was the most prevalent respiratory complication (24.84%), followed by pneumonia (18.2%), pleural effusion (16.5%), tuberculosis (12.3%), and obstructive sleep apnea (10.1%). Mean FEV₁ % predicted significantly declined from Stage 1 (95%) to Stage 5 (42%, p<0.001). Mean 6MWT distance decreased progressively (Stage 1: 487m vs Stage 5: 268m, p<0.001). Dyspnea severity correlated significantly with advancing CKD stage (r=0.78, p<0.001). SpO₂ below 92% was observed in 31.3% of Stage 4–5 patients. Multivariate analysis identified CKD stage (OR=2.41, 95% CI: 1.89–3.07), dialysis status (OR=1.87, 95% CI: 1.23–2.84), and anemia (OR=1.56, 95% CI: 1.02 2.38) as independent predictors of respiratory complications. Conclusion: Respiratory complications are highly prevalent in CKD patients with significant functional impairment and disease progression across kidney stages. Early respiratory assessment and integrated management strategies are essential for comprehensive CKD care and improved patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Meenakshi Academy of Higher Education and Research (IN), Physiotherapy New Zealand (NZ)
Good health and well-being
Openalex Percentile: Top 46%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.